Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kernel

Explore full profile

Neuroscience as a Service enables on-demand access to the world's most advanced brain recording technology

Culver City, United StatesFounded 2016Biotech & Life Sciences
Valuation $100–250M Last recorded · 2020
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Kernel and the history behind them.

About Kernel

Kernel is a pioneering startup in the field of precision neuroscience. They are leveraging their proprietary neurotechnology to create a comprehensive portfolio of brain-based biomarkers. The company's primary goal is to expedite the discovery of treatments, enhance patient outcomes, and revolutionize neuromedicine.

Read full description

Kernel's main product, Kernel Flow, is a first-of-its-kind neuroimaging headset that collects high-resolution data for precision neuroscience. It uses advanced artificial intelligence (AI) and machine learning (ML) tools to develop new biomarkers and derive actionable insights. The headset is portable and easy to set up, making it possible to bring research-grade neuroimaging to various real-world settings.

Kernel Flow combines high-resolution optical hemodynamic imaging, which provides measures similar to functional Magnetic Resonance Imaging (fMRI), with Electroencephalogram (EEG) measures. This combination provides advanced, multi-modal data for comprehensive insights. The technology is backed by over 5000 unique datasets and has been proven in the field.

Kernel also offers cloud-based analysis tools that provide seamless access to world-class data analyses. These tools are scalable, enabling the processing of individual datasets as well as large-scale population-level analyses.

The company's business model revolves around partnering with research institutions, healthcare providers, and pharmaceutical companies. They aim to improve clinical trial optimization, accelerate treatment development, and enhance neuromedicine by predicting treatment responses and enabling early identification of neurological conditions.

In summary, Kernel is a game-changer in the field of precision neuroscience, offering innovative neurotechnology solutions that have the potential to transform patient care and treatment discovery.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2016
Headquarters
Culver City, United States
Employees
57
Open positions
None listed
Dealroom signal
81.7/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Intelligent Systems, Ticketing, Entertainment, Biotechnology, Neurology, Tech for Medical Professionals, Biotech and Pharma
Technology
Hardware
Business model
Manufacturing
Client focus
b2b, b2c
Investment activity
1 company, latest Mar 2019
Capital deployed
$165M
Preferred round
LATE VC

Latest news

Press, funding announcements and product moves mentioning Kernel.

See all news

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCOther financing Nov 2023 $5.3M Undisclosed
SERIES COther financing Jul 2020 $53M $212M Manta Ray Ventures · Tiny Blue Dot · General Catalyst · Khosla Ventures
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Kernel website traffic

Latest recorded traffic for Kernel is 32K monthly website visits, up 33.3% over the last three months. Kernel's team grew 7.5% over the past year.

Latest monthly visits32K 3-month web change+33.3% 1-year team growth+7.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later6 investors entered at this stage

Team profiled 28 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States84.6%
🇬🇧 United Kingdom7.7%
🇲🇽 Mexico3.9%
🇩🇪 Germany3.9%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Kernel on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kernel’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.